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Hepatic Arterioportal Shunts: Dynamic
CT and MR Features
With the increased temporal resolution available in dynamic computed tomog-
raphy (CT) and magnetic resonance imaging (MRI), hepatic arterioportal shunts
are now more frequently encountered than in the past. The condition occurs in
various hepatic diseases in which portal or hepatic venous flow is compromised.
The underlying mechanism and the degree of shunt affect its appearance at
dynamic imaging. The dynamic CT and MRI findings have been summarized as
early enhancement of peripheral portal veins, and wedge-shaped transient
parenchymal enhancement during the hepatic arterial phase. Recognition of arte-
rioportal shunt can suggest the presence of a previously unsuspected disorder
and avoids false-positive diagnosis or overestimation of a hepatic disease.
Familiarity with the pathophysiology of arterioportal shunt also allows investiga-
tion of the hepatic hemodynamic changes occurring in various hepatic diseases.
ultiphase dynamic computed tomography (CT) and magnetic resonance
imaging (MRI) can provide useful information for the differential diagno-
sis of various hepatic lesions by highlighting dynamic contrast enhance-
ment features. Furthermore, careful analysis of the patterns observed is helpful in the
evaluation of hepatic hemodynamic change. In fact, hemodynamic abnormalities are
commonly encountered in daily practice as a result of the increased use of dynamic CT
and MRI. In order to properly characterize liver tumors and avoid erroneous identifi-
cation of pseudolesions, knowledge of these lesions thus becomes more important. At
hepatic arterial phase (HAP) imaging, perfusion disorders are generally seen as an area
of hyperenhancement that returns to normal at portal venous phase (PVP) imaging. In
most cases, this finding reflects increased arterial blood flow related to arterioportal
shunt (APS). The causes of APS include obstruction of the portal or hepatic vein, liver
cirrhosis, hepatic neoplasms, hepatic trauma, hepatic parenchymal compression, and
inflammatory diseases (1). In this article, we discuss the pathophysiology of APS, its
dynamic CT and MRI findings, and various causes.
PATHOPHYSIOLOGY
APS is an organic or functional communication between the hepatic arterial branch
and the portal venous system, resulting in the redistribution of arterial flow into a focal
region of the portal venous flow. When blood flow through the portal vein is dimin-
ished or absent, the hepatic artery takes over perfusion of the liver through the APS
(2). In cases of portal vein obstruction and compression, increased hepatic arterial
blood flow occurs mainly through the peribiliary plexus (3).
APS may involve a number of different routes, each of which can occur alone or in
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Mcombination with other mechanisms. In the transsinusoidal
route, flow is from the hepatic artery to the hepatic sinu-
soids and then, retrogradely, into branches of the portal
vein because of high resistance to flow through the hepatic
venules (4). This mechanism is believed to be responsible
for nontumorous APS in cirrhosis or Budd-Chiari syn-
drome. In the transvasal route, a vasa vasorum from a
branch of the hepatic artery passes through the wall of a
branch of the portal vein and allows blood to flow into the
lumen of the portal vein (due to a tumor thrombus) (5).
Cho et al. (6) postulated that an APS can occur through the
peribiliary vascular plexus (transplexal or peribiliary
route), which is supplied by the hepatic artery and drains
into either the portal vein via interlobular veins or into the
sinusoids via lobular veins. Where the portal vein is oc-
cluded, this pathway may be responsible for the most
prominent arterioportal communication (3). APS can also
occur in a hypervascular tumor such as hepatocellular car-
cinoma (HCC) or hemangioma, via its draining vein (trans-
tumoral route) (7). Lastly, a macroscopic arterioportal fis-
tula may be caused by trauma such as penetrating injury of
the liver (8).
Compromise in portal venous flow and APS
Diminished or absent portal flow occurs under different
conditions, including portal vein obstruction due to tumor
or bland thrombus, portal vein compression by intra- and
extrahepatic tumors or hematoma, increased pressure on
the hepatic parenchyma, and surgical ligation of the portal
vein (3). The compensatory increase in hepatic arterial
flow in cases of portal vein obstruction and compression
was first demonstrated radiologically at dynamic CT by Itai
et al. (9), and then angiographically by Matsui et al. (10).
Compromise in hepatic venous flow and APS
Hepatic venous flow decreases under certain conditions,
including obstruction of the hepatic vein due to tumorous
or bland thrombus; compression of the hepatic vein by he-
patic tumors or hematoma; Budd-Chiari syndrome; right-
sided cardiac failure; and mediastinal fibrosis (1). The he-
modynamics in such cases seem to be very complex, and
have yet to be investigated. 
When the hepatic vein is acutely obstructed, it has been
generally believed that the pressure gradient between the
sinusoids and portal veins is reversed and the portal vein
becomes a drainage channel, resulting in a functional APS
and increased hepatic arterial flow (11, 12). The typical CT
finding of a heterogeneous reticular enhancement pattern
in Budd-Chiari syndrome has been attributed either to the
portal vein fulfilling a drainage role (13), or to the dilated
lymphatic vessels (14). However, it has become controver-
sial whether portal flow is reversed in affected areas, since
Hiraki et al. (15) recently reported that they failed to
demonstrate reversed portal flow in their cases.
IMAGING FINDINGS
Dynamic CT
Regardless of the mechanism of APS, its dynamic CT
findings are as follows: (a) the early enhancement of pe-
ripheral portal vein branches before the central portal vein
is enhanced; and (b) transient hepatic attenuation differ-
ence (THAD) (1, 16, 17). CT also depicts the underlying
cause of APS, including a tumor, inflammatory lesion, and
thrombosis or compression of the portal or hepatic vein. 
While one of the direct CT findings of APS is early en-
hancement of the affected peripheral portal vein, this find-
ing is noted less frequently than at hepatic angiography
(18), a discrepancy thought to be due to the limited resolu-
tion of CT in demonstrating small portal branches of the
liver.
THAD indicates transient, peripheral, wedge-shaped he-
patic parenchymal enhancement - usually with a straight
margin - during HAP (9) (Fig. 1): this arises because in-
creased arterial flow compensates for diminished portal
flow, and because the passage of contrast material from
high-pressure arterial blood into a low-pressure portal
branch enhances the focal area of the liver while contrast
material in the adjacent parenchyma is diluted by the
nonopacified portal venous flow (1, 17). PVP dynamic
imaging shows that the involved site returns to normal or
nearly normal attenuation, though a defect is observed at
CT during arterial portography (7). Normal vessels course
through the area of THAD (1, 17). 
APS due to diminished hepatic venous flow
Where there is diminished hepatic venous flow, dynamic
CT or MRI findings may differ according to the site and
chronicity of the occlusion as well as the development of
veno-venous collaterals (1, 19). Transient hepatic hyperen-
hancement may be seen at HAP imaging, and this area has
been reported to correspond to a defect seen at CT during
arterial portography and/or hyperattenuation seen at CT
during hepatic arteriography (12), as in cases of portal ve-
nous flow stoppage. The differences are that (a) the straight
border of the involved parenchyma intersects with the cor-
responding branch of the hepatic vein in portal venous oc-
clusion and vice versa in hepatic venous occlusion (16),
and (b) the vertex of the wedge-shaped hyperattenuating
area points to the hepatic hilum in portal venous occlusion,
but to the inferior vena cava in hepatic venous occlusion
(1, 16) (Fig. 2). A recent experimental study (19) revealed
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poattenuation in the affected area during PVP imaging,
probably because APS occurred at the presinusoidal level
(through the transplexal route) and the reversed opacified
portal flow escaped from the congested segment. This flow
then drained into the segment adjacent to the patent hepat-
ic vein, resulting in transient hyperenhancement.
Interestingly, a congested segment was often hyperattenu-
ated at subsequent delayed-phase imaging, a finding which
was attributed to delayed washout of the contrast agent
(Fig. 2).
The relationship between degree of APS and its ap-
pearance at dynamic CT
Most APS are asymptomatic and rarely of sufficient mag-
nitude to result in total hepatofugal portal venous flow.
However, if flow through an APS is extremely high, hy-
perkinetic portal hypertension, ischemic colitis, and even
heart failure may be associated (8, 20). Successful treat-
ment of hyperkinetic portal hypertension in these patients,
Dynamic CT and MR Features in Hepatic Arterioportal Shunts
Korean J Radiol 3(1), March 2002 3
Fig. 2. Attenuation differences secondary to hepatic vein obstruction in a transplanted liver.
A. CT scan obtained during portal venous phase shows hypoattenuation of the anterior segment of the transplanted right lobe despite
normal enhancement of the portal veins (arrowheads) inside the corresponding area.
B. CT scan obtained during the equilibrium phase reveals thrombosed hepatic vein (arrow) which was ligated during surgery. The anteri-
or segment of the transplanted right lobe appears hyperattenuated, producing a negative image of (A). Note that the straight border
(small arrows in (A) and (B)) of transient hepatic attenuation difference intersects the portal veins (open arrows in (A) and (B)).
AB
Fig. 1. Portal vein thrombosis occurring in pylephlebitis.
A. CT scan obtained during hepatic arterial phase shows transient high attenuation of the right anterior segments of the right lobe and
segments III and IV (arrows).
B. Portal venous phase image shows bland thrombi, producing inflow obstruction, within the portal veins (arrows). The portal vein sup-
plying segment II is patent (arrowheads). Note that the straight border of transient hepatic attenuation difference on the hepatic arterial
phase image (arrows in (A)) intersects the hepatic vein (small arrow in (B)).
ABwith restoration of hepatopetal portal flow, has been de-
scribed (20). 
Whereas high-flow APS shows a variable amount of ret-
rograde flow through the portal vein (Fig. 3), sometimes
with reflux to the contralateral side or collaterals at HAP
imaging, low-flow APS involving smaller portal branches is
often seen at dynamic CT only as a THAD (7, 18, 21).
Whereas high-flow APS is usually associated with organic
shunt through macroscopic arterioportal fistulas or along
the transvasal route (i.e. HCC), low-flow APS is associated
with functional shunt which follows the transplexal or
transsinusoidal route, though there are exceptions and con-
siderable overlap (1, 16). 
The fistulous point of APS can be located at the apex of
the wedge-shaped hyperattenuated area or within this area
(16, 17); the location probably depends on the flow rate
through the shunt. If reversed portal flow is greater, the
wider area shows hyperattenuation during HAP imaging
due to the redistribution of contrast material from the re-
versed portal flow. Therefore, the dynamic CT appearance
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Fig. 4. Arterioportal shunt secondary to hemangioma in a patient with pancreatic carcinoma.
A. CT scan obtained during hepatic arterial phase shows a hemangioma (arrow) at the right lobe of the liver.
B. Follow-up CT scan obtained six months later shows wedge-shaped transient hyperattenuation of the adjacent parenchyma (arrows),
with early opacification of the peripheral portal veins (arrowheads). Another area of transient parenchymal enhancement is apparent
(open arrow), and was secondary to another small hemangioma in contiguous section (not shown). The change observed in the degree
of Arterioportal shunt between figures (A) and (B) might be due to diminished portal blood flow caused by severe stenosis of the main
portal vein (not shown).
AB
Fig. 3. Arterioportal fistula in a 42-year-old man with symptoms of portal hypertension such as recurrent gastrointestinal bleeding and as-
cites. He had undergone percutaneous liver biopsy seven years earlier.
A. A maximum-intensity projection image of CT scans obtained during hepatic arterial phase shows hyperattenuation of the right lobe of
the liver, with an enlarged hepatic artery (arrowheads).
B. Celiac angiogram demonstrates that shunted arterial flow from the fistulous point (arrow) is instantaneously drained into portal branch-
es in the entire right lobe of the liver. Subsequent embolization of the fistula relieved this patient’s symptoms.
ABof APS can be affected by the degree of shunt (Fig. 4). 
The presence and degree of APS, and thus its appearance
at dynamic CT, represent, in many cases, the state of dy-
namic equilibrium. For example, it has been reported that
in cirrhotic patients with nontumorous APS, the increased
venous portal flow arising after a meal caused hepatofugal
flow to change to hepatopetal (22).
Iodized-oil CT
Iodized oil retained in peripheral hepatic parenchyma
because of APS appears as a triangle or wedge shape (Fig
5). Iodized oil in the hepatic artery reaches the portal sys-
tem through the shunt, resides in the sinusoid of hepatic
lobules, and remains there for up to several weeks. Much
more of it is retained there than in the rest of the
parenchyma without APS (23).
Dynamic MRI
In APS, the dynamic MRI findings are basically the same
as those of dynamic CT. Although investigations have
been less intense than with CT, several studies (24 27)
have reported the dynamic MRI findings of APS as fol-
lows: (a) early enhancement of the branches of the periph-
eral portal vein; and (b) subcapsular wedge-shaped homo-
geneous enhancement of the parenchyma during HAP,
which is the MRI form of THAD (Fig. 6).
MRI has demonstrated these findings less frequently than
has hepatic angiography (24); the difference is thought to
be due to several technical factors involved in image acqui-
sition, including limited spatial and temporal resolution and
the magnetic field inhomogeneity produced by phased-ar-
ray multicoils. Discussions provoked by this issue have
been excellently summarized in a recent article by Yu et al.
(24).
Unenhanced T1- and T2-weighted images
In most patients with APS, unenhanced T1-and T2-
weighted imaging reveals no focal abnormal signal intensi-
ty that corresponds to the wedge-shaped region of hyper-
enhancement seen during HAP (24, 25). However, focal
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Fig. 5. Arterioportal shunt secondary to percutaneous ethanol in-
jection therapy in a patient with HCC.
A. CT scan obtained during portal venous phase shows a perfu-
sion defect at the site of previous percutaneous ethanol injection
therapy (arrows), as well as multiple nodular tumors with iodized-oil
uptake (arrowheads). An extrahepatic metastatic nodule, probably
located at the previous needle tract for another percutaneous
ethanol injection therapy (open arrow), is visible.
B. Celiac angiogram obtained before transarterial chemoemboliza-
tion indicated an area of patchy staining (arrowheads) in the right
hepatic lobe due to the presence of arterioportal shunt, as well as
various other nodular staining lesions (arrows).
C. Precontrast CT obtained two weeks after transarterial
chemoembolization shows wedge-shaped retention of iodized oil in
the area corresponding to arterioportal shunt (arrowheads). Follow-
up CT (not shown) indicated that in contrast to other nodular up-
take by tumors, this retention had washed out. 
C
ABabnormal signal intensity has been reported in correspond-
ing areas at unenhanced T1 and T2 weighted imaging,
though the frequency has not been determined. Several re-
searchers have observed high signal intensity in these areas
at T2-weighted images (24, 28, 29) (Fig. 7). And this may
be related to the secondary changes occurring in portal ve-
nous obstruction. If the intrahepatic portal vein is occluded
for whatever reason, hepatic arterial flow is insufficiently
compensated, and the liver parenchyma is injured in ways
which include edema, hepatocytic depletion, and fibrosis,
which may be presumed to be a cause of T2 prolongation
(24, 28, 29). Conversely, T1-and T2-weighted imaging has
revealed a segmental hypointense area, attributable to he-
mosiderin deposition (30).
Superparamagnetic iron oxide (SPIO)-enhanced im-
ages
With the introduction of SPIO-enhanced MRI, the possi-
ble relation between APS and iron metabolism has been
shown to be more complex than previously thought. It has
been reported that impaired portal perfusion might de-
crease the uptake of SPIO in histopathologically normal
liver parenchyma (31), resulting in reduced signal loss at
SPIO-enhanced MRI. Mori et al. (32) also reported that
since Kupffer cells and hepatocytes are not injured in non-
tumorous APS without obstruction of the portal vein, the
signal loss was more pronounced in tumorous APS in
which the associated portal branches were obstructed, than
in nontumorous APS. 
CAUSES
Hepatocellular carcinoma (HCC)
HCC is sometimes associated with compromise of the
portal or -less frequently- hepatic vein, and subsequent
APS via the transvasal, the transtumoral or the transsinu-
soidal route (1). Alternatively, where the portal vein is
compromised, the transplexal route may be involved (1,
17). 
Early invasion of the branches of the portal vein is fre-
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Fig. 6. Arterioportal shunt secondary to hemangioma.
A. T2-weighted MRI shows an exophytic hemangioma (arrow) with
bright signal intensity in the left lobe of the liver.
B. Gadolinium-enhanced dynamic MRI obtained during hepatic ar-
terial phase shows a focal hyperintense area due to arterioportal
shunt in adjacent parenchyma (arrows), as well as peripheral
nodular enhancement of the hemangioma (arrowheads).
C. Further cranial section demonstrates early enhancement of the
peripheral portal veins (arrows).
C
ABquent, and there may be propagation along a branch of the
portal vein away from the tumor or even into the main
portal vein, where it manifests as a tumor cast demonstrat-
ing the ‘thread and streaks’ sign at hepatic angiography
(33) or CT (34) (Fig. 8). Since the tumor thrombi are hy-
pervascular and supplied by the vasa vasorum of the portal
vein wall (33), blood from the hepatic artery may run
through the tumor thrombi and drain into the lumen of the
portal vein (transvasal route) (5). Where an APS shows ex-
tensive high flow, the shunted arterial flow is directed to
the adjacent hepatic segment or contralateral hepatic lobe.
Occasionally, hepatofugal flow can be recognized on HAP
images (1). In HCC, macroscopic invasion of the portal
vein substantially worsens the prognosis, and the detection
of such invasion is thus important. Dynamic CT can
demonstrate arterial enhancement within a tumor throm-
bus, thus allowing differentiation from bland thrombus
(35). 
APS around a tumor can involve the transtumoral route,
along which venous drainage of the tumor into the periph-
eral portal vein occurs. Both dynamically, employing sin-
gle-level dynamic CT, and statically, using histologic speci-
mens, Ueda et al. (36) demonstrated blood drainage from
HCCs into the portal vein. 
It has been suggested that a hypervascular tumor can
‘steal’ arterial blood from its surrounding parenchyma (9),
but this mechanism does not seem to have an important ef-
fect on the appearance of APS at dynamic imaging (1). 
Where HCC involves invasion and occlusion of the he-
patic vein, the presence of arterio-hepatic venous shunt
along with coexisting invasion of the portal vein compli-
cates the interpretation of the hemodynamics, often exag-
gerating the extent of the tumor at dynamic CT (Fig. 9) or
MRI.
Transarterial chemoembolization (TACE)
TACE is an effective treatment method in the manage-
ment of patients with inoperable HCC (37). Because this
procedure may cause hepatic infarction followed by hepat-
ic failure in the patients with large APS, the presence of
Dynamic CT and MR Features in Hepatic Arterioportal Shunts
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Fig. 7. Arterioportal shunt secondary to hepatocellular carcinoma.
A. CT scan obtained during hepatic arteriography shows wedge-
shaped hyperperfusion (arrowheads) around the tumor (arrows).
B. CT performed during arterial portography shows a perfusion de-
fect at the corresponding area (arrowheads).
C. T2-weighted MRI shows a hyperintense area (arrowheads)
around the tumor (arrows), which corresponds to the area of arteri-
oportal shunt.
C
ABAPS or portal venous thrombosis may affect the method of
treatment (38). If APS is present, the embolic agent will be
diverted to branches of the portal vein and delivered to
normal areas of the liver instead of being deposited in the
tumor, a problem which can be overcome by pinpoint or
superselective embolization of the APS using micro-
catheters if the condition is diagnosed before treatment
(39). 
In addition, TACE itself may be a cause of nontumorous
APS (18). The etiology of APS after TACE is not known,
but some investigators have speculated that peripheral ar-
terial occlusion with subsequent dilatation of peribiliary ar-
terioportal communication, with or without associated
parenchymal damage, may give rise to this phenomenon.
An APS subjected to TACE tends to be larger than other
cirrhosis-related nontumorous APS (1) (Fig .9). 
Other malignant tumors
Other malignant tumors, including cholangiocarcinoma
and those arising through metastasis (Fig. 10), may cause
APS by direct obstruction or compression of the portal
veins. This results in an area of transient hyperenhance-
ment peripheral to the tumor, as seen at dynamic CT (39,
40) or MRI (40), which corresponds to the wedged-shaped
perfusion defect demonstrated at CT during arterial por-
tography.
Choi et al.
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Fig. 8. A 53-year-old man with hepatocellular carcinoma.
A. CT scan obtained during the aortic phase shows a ‘thread-and-streak’ sign at the tumor thrombus in the portal vein (arrowheads).
B. Hepatic arterial phase image shows diffuse hepatocellular carcinoma with heterogeneous attenuation in the right lobe invading the
right hepatic vein and inferior vena cava (arrowheads). Note the ‘thread-and-streak’ sign at the tumor thrombus.
C. CT scan obtained caudad to figure (B) shows diffuse hepatocellular carcinoma in the right lobe invading the portal vein (arrowheads).
The straight border at the left lobe (arrows) does not indicate the tumor margin but appears to be caused by arterioportal shunt. Note that
blood flow in the inferior accessory hepatic vein (open arrow) is highly opacified.
D. Portal venous phase image shows an area of abnormal hyperattenuation at segment VI (arrowheads). In this case, the shunted flows
from the tumor thrombus in the hepatic and portal veins seem to drain into segment VI and then into the inferior accessory hepatic vein.
CD
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Fig. 9. Arterioportal shunt secondary to transarterial chemoem-
bolization.
A. CT scan obtained during hepatic arterial phase shows peripher-
al wedge-shaped hyperattenuation caused by arterioportal shunt at
the left lobe of the liver (arrowheads). Note the nodular iodized-oil
uptake (arrows) inside the hyperattenuating area.
B. Portal venous phase image shows that parenchymal enhance-
ment has returned to normal. Note the retracted capsule (arrow)
and minimally dilated bile ducts (arrowheads); both findings may in-
dicate the presence of ischemic injury due to repeated transarterial
chemoembolization.
C. Left hepatic arteriogram reveals wedge-shaped staining and ret-
rograde opacification of the peripheral portal vein in the corre-
sponding area (arrows) and other areas (arrowheads).
C
AB
Fig. 10. Arterioportal shunt secondary to cholangiocarcinoma.
A. CT scan obtained during hepatic arterial phase shows diffuse hyperattenuation at the left lobe of the liver, as well as a large hypoat-
tenuating mass (arrowheads) and dilated bile ducts.
B. Portal venous phase image demonstrates that parenchymal enhancement has returned to nearly normal. Note that the left portal vein
is encased by the tumor (arrow).
ABHemangioma
Although it has been generally recognized that APS is
rare in hepatic hemangiomas (41), Kim et al. (42) recently
reported that according to the findings of dynamic CT, a
relatively high percentage of hemangiomas (25.7%) are ac-
companied by APS. With the increased use of multiphase
dynamic imaging of the liver, more hemangiomas are im-
aged during HAP, thereby demonstrating APS (Figs. 4, 6).
The occurrence of APS is more frequent in hemangiomas
which show rapid enhancement (41, 42). In most cases, he-
mangioma-associated APS is low-flow.
Liver cirrhosis
Cirrhosis alone is a well-known cause of APS on dynam-
ic CT (18, 21) and MRI (24) (Fig. 11). Angiography
demonstrates that the frequency of nontumorous APS in
liver cirrhosis is very high (up to 13%) (21), but the detec-
tion of this lesion by dynamic CT (18, 24) or MRI (21, 24)
seems to be lower than on angiography. A nontumorous
APS occurring in liver cirrhosis is rarely of sufficient mag-
nitude to result in total hepatofugal portal venous flow
(21). 
Nontumorous APS in liver cirrhosis is believed to be sec-
ondary to the observed occlusion of the small hepatic
venules and the retrograde transsinusoidal filling of the
small branches of the portal vein (4, 5, 18). This latter be-
comes a draining rather than a supplying vein, and CT dur-
ing arterial portography shows these lesions as perfusion
defects. Moreover, there is a compensatory increase in he-
patic arterial flow resulting in a functional APS (3). A re-
cent scanning electron microscopy study has demonstrated
that hypertrophy of the peribiliary plexus in the central
area of the liver and direct anastomosis in the peripheral
area of the liver are major routes of arterioportal commu-
nication in experimental rat cirrhosis (43). Changes in the
capillarization and permeability of sinusoids may also be
related to arterioportal communication in cirrhotic liver
(43, 44). 
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Fig. 11. Nodular-shaped nontumorous arterioportal shunt mimick-
ing hepatic tumor in cirrhotic liver.
A. CT scan obtained during hepatic arterial phase shows a nodular
hyperattenuating lesion (arrow) in the right lobe of the liver. Note
the subtle, tiny portal branch inside the lesion.
B. Subsequent hepatic angiogram shows multiple patchy areas of
staining in the liver (arrowheads), with early opacification of the
portal veins.
C. Follow-up CT scan obtained during hepatic arterial phase shows
no hyperattenuating lesion in the same area, indicating that the le-
sion depicted in (A) was a nontumorous arterioportal shunt.
C
ABTumorous or nontumorous APS?
Where HAP imaging of cirrhotic liver reveals a hyperat-
tenuated focal hepatic lesion, this is usually HCC (1).
However, the presence of a nontumorous APS in cirrhotic
liver produces the same or similar appearance (18, 21).
Differentiation between APS and tumors is, therefore, not
always easy (21). Conversely, when a tumorous APS de-
velops adjacent to a small HCC, it is sometimes difficult to
detect the tumor in the APS because the whole APS area is
enhanced during HAP. In some cases of HCC, only THAD
is observed at CT (1, 16). 
In most cases, however, a peripheral location, a wedge-
shape, a straight-line margin, and the presence of normal
vessels coursing through these lesions make a diagnosis of
APS very likely (16, 26) (Fig. 12). Because of the three-di-
mensional relationship of the lesion and the direction of
the CT section, nontumorous APS may be round or nodu-
lar in appearance (Fig. 13). If the entire lesion has cone
shape in three-dimensional configuration, this is an impor-
tant clue for differentiation of a flow-related lesion from a
hepatic tumor (3). 
Because a tumor is usually seen during the equilibrium
phase as an area of heterogeneous low attenuation (or in-
tensity), while the attenuation (or intensity) of a nontumor-
ous APS never decreases below that of surrounding liver
parenchyma (45), it is the equilibrium phase which is most
useful for differentiation between a hypervascular tumor
and APS (Fig.12). 
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Fig. 12. Tumorous (hepatocellular carcinoma) and nontumorous arterioportal shunt in cirrhotic liver.
A, B. CT scans obtained during hepatic arterial phase depict focal hyperattenuating lesions in segment II (arrow in (A)) and segment VI
(arrow in (B)). Both lesions are rectangular-shaped and located in subcapsular areas. Note the enhanced peripheral portal vein (arrow-
heads in (A)) inside the lesion in segment II.
C, D. Portal venous phase images show no lesion in segment II, indicating that the lesion depicted in (A) is a nontumorous arterioportal
shunt; however, a nodular hypoattenuating lesion with rim enhancement is seen in segment VI (arrow in (D)), indicating hepatocellular
carcinoma. Note that the size and shape of the lesion in segment VI differ slightly between the hepatic arterial phase (B) and portal ve-
nous phase (D) images, indicating the presence of arterioportal shunt around the tumor.
CD
ABWith regard to the transient parenchymal hyperenhance-
ment seen during HAP at dynamic MRI, normal findings
on unenhanced T1- and T2-weighted imaging may help ex-
clude hypervascular tumor (24). As previously mentioned,
however, APS can be associated with focal hyperintensity
at T2-weighted imaging. Moreover, a number of small
HCCs can be detected only on HAP images, with no distin-
guishable abnormalities apparent at unenhanced T1- and
T2-weighted MRI (46). 
If the findings of dynamic CT or MRI are inconclusive,
other studies such as arteriography, iodized-oil CT, or ul-
trasonography must be performed to exclude the possibili-
ty of a tumor or tumorous APS (18). In the case of nontu-
morous APS, no focal nodular iodized oil uptake is identi-
fiable at iodized-oil CT (18, 21). If a suspected lesion is
small, follow-up CT or MRI at 1-3-month intervals is help-
ful before performing invasive diagnostic procedures or
treatment. The nontumorous enhancing lesions produced
by reactive hyperemia and APS are usually resolved dur-
ing this follow-up period. (47) (Fig. 11). 
Trauma
Abdominal trauma and radiologic interventional proce-
dures sometimes cause an organic communication between
the arterial and portal venous systems or produce function-
al APS due to portal vein injury such as portal vein throm-
bosis (1). The increasing use of interventional radiologic
procedures such as percutaneous biopsy (23, 48) (Fig. 3),
ethanol injection (26, 49) (Fig. 5), and radiofrequency abla-
tion (47) has increased the frequency with which these
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Fig. 13. Arterioportal shunt secondary to hepatic abscess.
A, B. CT scans obtained during hepatic arterial phase show a hepatic abscess (arrow), with wedge-shaped hyperattenuation (arrow-
heads) in the adjacent parenchyma.
C, D. Portal venous phase images depict abscess wall enhancement, and the demarcation of the abscess is clearer than in the hepatic
arterial phase image (arrow). Portal venous phase images show that parenchymal enhancement has returned to normal. Note that the
wedge-shaped parenchymal hyperattenuation demonstrated by hepatic arterial phase imaging points to the thrombosed hepatic vein (ar-
rowheads).
CD
ABAPS cases are revealed by dynamic CT and MRI. Most of
these iatrogenic APS are asymptomatic, and are significant
in that the observed focal perfusion abnormalities may be
confused with those of a tumor (1). However, it is usually
not difficult to distinguish iatrogenic APS from a new tu-
mor or marginal recurrence by evaluating its characteristic
configuration and location (49). The majority of iatrogenic
APS close spontaneously and very rapidly (48), and persis-
tent high-flow arterioportal fistulas causing hyperkinetic
portal hypertension are considered relatively rare (8). In
order to prevent equivocal or false-positive findings on
subsequent iodized-oil CT, TACE shortly after biopsy is
not recommended. 
Inflammatory diseases
The actual mechanism of APS in inflammatory diseases
has not been as intensively investigated as in HCC. Local
inflammation can cause hyperemia of the hepatic artery
and stoppage of regional portal or hepatic venous flow, as
in cases of hepatic abscess (27, 50), acute cholecystitis (51),
and cholangitis (17). 
The transient wedge-shaped hyperattenuated or hyperin-
tense area around the hepatic abscess, seen at dynamic CT
(50) and MRI (27), is mainly attributed to portal vein
thrombosis (27) or stenosis due to periportal inflammation
(50). In our experience, the frequency of this transient hy-
perattenuation is high in abscess cases, a finding which
seems to be associated with thrombosis of both the hepatic
and portal vein (Fig. 13). In many cases, however, it is
practically impossible to determine whether the abscess is
secondary to pylephlebitis or vice versa (Fig. 1).
Acute cholecystitis as a cause of transient hepatic hyper-
attenuation has also been reported, and is caused either by
the increased blood flow from the dilated aberrant cystic
vein of diseased hypervascular gallbladder (51) or by
thrombosis of regional portal or hepatic veins. 
Aberrant vascular supply
Certain nonportal splanchnic or systemic venous supplies
to normal hepatic parenchyma, so-called ‘third inflow
tracts’, can be exaggerated in pathologic states (1). For ex-
ample, an aberrant right gastric vein draining directly into
the liver parenchyma (segment IV) has been described in
anatomic investigations (52). 
The hepatic regions supplied by these third inflow tracts
have many hemodynamic features in common with the re-
gions affected by APS, though the underlying mechanism
is completely different. The hepatic regions supplied by
third inflow tracts have the same imaging features as seen
in APS, appearing as defects at CT during arterial portog-
raphy (52), as hyperattenuating areas at CT during hepatic
arteriography (53), and as transient hyperattenuating areas
during HAP in dynamic imaging (1). These phenomena are
also explained by the finding that the inflow of gastric or
cystic venous blood through the third inflow tract occurs
earlier than that of intestinal splanchnic venous blood from
the portal trunk (1). 
Uneven fatty liver related to APS
The association between diminished portal supply and
focal fat deposition or sparing has been intensively investi-
gated in patients with a third inflow tract (1, 3, 54). It
seems likely that in diffuse fatty liver, focal sparing occurs
if there is no portal flow (3, 54). Decreased portal flow
may, however, induce focal fatty deposits in non-fatty liver
(1, 55). It is uncertain why decreased portal flow may
cause focal fatty infiltration in some cases, while giving rise
to spared areas in others. 
Likewise, APS can induce focal sparing in the diffuse fat-
ty liver through increased non-lipid-rich arterial flow and
decreased lipid-rich portal flow. Focally spared areas have
been reported around or distal to tumors such as HCC and
hemangioma (56). Although the resultant focal sparing in
diffuse fatty liver can be imaged using ultrasonography and
CT, chemical-shift MRI demonstrates this lesion most dra-
matically (57). 
Miscellaneous
Congenital APS, although rare, has been reported in pa-
tients with arterioportal fistula, hereditary hemorrhagic
telangiectasia, Ehlers-Danlos syndrome, and others (17).
Any cause of thromboembolism or air embolism in the
portal system can induce APS. Possible causes include ab-
dominopelvic surgery, bowel infarction, infectious process-
es (e.g. sepsis or appendicitis), neoplasms that invade or
compress the portal venous system (e.g. pancreatic cancer),
hypercoagulative states, myeloproliferative disorders, and
noninfectious inflammatory processes (e.g. pancreatitis)
(1). 
Severe extrinsic compression of the liver due, for exam-
ple, to rib compression, perihepatic peritoneal implants,
pseudomyxoma peritonei, or perihepatic fluid collection
can also be included as a rare cause of APS (1, 58). In this
situation, low-pressure hepatic veins and/or hepatic sinu-
soids may be preferentially compressed and transplexal
shunt may develop.
CONCLUSIONS
APS, an important hemodynamic alteration in the liver,
will continue to be demonstrated with greater frequency
because the temporal resolution of dynamic CT and MRI is
Dynamic CT and MR Features in Hepatic Arterioportal Shunts
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Recognition of arterioportal shunt can suggest the pres-
ence of an unsuspected disorder and avoids false-positive
diagnosis or overestimation of a hepatic disease.
Familiarity with the pathophysiology of arterioportal shunt
also allows investigation into the hemodynamic changes
occurring in the liver in various hepatic diseases.
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